3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide

C101H114FN25O10 — CID 158997304

IUPAC3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide
SMILESCc1ccc(C(=O)Nc2ccc3c(OCC4CCCC4)nn(C)c3c2)nc1.Cn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ccc(F)cn3)cc21.Cn1nc(OCC2CCCCC2)c2ccc(NC3=NCc4cccnc43)cc21.Cn1nc(OCC2CCCCC2)c2ncc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCOC2)c2ccc(NC(=O)c3nccnc3N)cc21
InChIInChI=1S/C22H25N5O.C21H24N4O2.C20H21FN4O2.C20H24N6O2.C18H20N6O3/c1-27-19-12-17(25-21-20-16(13-24-21)8-5-11-23-20)9-10-18(19)22(26-27)28-14-15-6-3-2-4-7-15;1-14-7-10-18(22-12-14)20(26)23-16-8-9-17-19(11-16)25(2)24-21(17)27-13-15-5-3-4-6-15;1-25-18-10-15(23-19(26)17-9-6-14(21)11-22-17)7-8-16(18)20(24-25)27-12-13-4-2-3-5-13;1-26-16-10-14(24-19(27)17-15(21)8-5-9-22-17)11-23-18(16)20(25-26)28-12-13-6-3-2-4-7-13;1-24-14-8-12(22-17(25)15-16(19)21-6-5-20-15)2-3-13(14)18(23-24)27-10-11-4-7-26-9-11/h5,8-12,15H,2-4,6-7,13-14H2,1H3,(H,24,25);7-12,15H,3-6,13H2,1-2H3,(H,23,26);6-11,13H,2-5,12H2,1H3,(H,23,26);5,8-11,13H,2-4,6-7,12,21H2,1H3,(H,24,27);2-3,5-6,8,11H,4,7,9-10H2,1H3,(H2,19,21)(H,22,25)
InChIKeyJQWWLBIRZCEAJR-UHFFFAOYSA-N
MW1857.19 g/mol
LogP17.10
Rot. Bonds24

About 3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide

3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide (PubChem CID 158997304) has the molecular formula C101H114FN25O10 and a molecular weight of 1857.19 g/mol. Its IUPAC name is 3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide.

Molecular Properties

Compound Name3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide
PubChem CID158997304
Molecular FormulaC101H114FN25O10
Molecular Weight1857.19 g/mol
Exact Mass1855.92
IUPAC Name3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide
SMILESCc1ccc(C(=O)Nc2ccc3c(OCC4CCCC4)nn(C)c3c2)nc1.Cn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ccc(F)cn3)cc21.Cn1nc(OCC2CCCCC2)c2ccc(NC3=NCc4cccnc43)cc21.Cn1nc(OCC2CCCCC2)c2ncc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCOC2)c2ccc(NC(=O)c3nccnc3N)cc21
InChIInChI=1S/C22H25N5O.C21H24N4O2.C20H21FN4O2.C20H24N6O2.C18H20N6O3/c1-27-19-12-17(25-21-20-16(13-24-21)8-5-11-23-20)9-10-18(19)22(26-27)28-14-15-6-3-2-4-7-15;1-14-7-10-18(22-12-14)20(26)23-16-8-9-17-19(11-16)25(2)24-21(17)27-13-15-5-3-4-6-15;1-25-18-10-15(23-19(26)17-9-6-14(21)11-22-17)7-8-16(18)20(24-25)27-12-13-4-2-3-5-13;1-26-16-10-14(24-19(27)17-15(21)8-5-9-22-17)11-23-18(16)20(25-26)28-12-13-6-3-2-4-7-13;1-24-14-8-12(22-17(25)15-16(19)21-6-5-20-15)2-3-13(14)18(23-24)27-10-11-4-7-26-9-11/h5,8-12,15H,2-4,6-7,13-14H2,1H3,(H,24,25);7-12,15H,3-6,13H2,1-2H3,(H,23,26);6-11,13H,2-5,12H2,1H3,(H,23,26);5,8-11,13H,2-4,6-7,12,21H2,1H3,(H,24,27);2-3,5-6,8,11H,4,7,9-10H2,1H3,(H2,19,21)(H,22,25)
InChIKeyJQWWLBIRZCEAJR-UHFFFAOYSA-N
XLogP17.10
TPSA427.54 Ų
H-Bond Donors7
H-Bond Acceptors31
Rotatable Bonds24
Heavy Atoms137
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001857.19
LogP ≤ 517.10
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1031

Analyze 3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide?
The IUPAC name of 3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide (CID 158997304) is 3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide.
What is the SMILES notation for 3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide?
The canonical SMILES for 3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide is Cc1ccc(C(=O)Nc2ccc3c(OCC4CCCC4)nn(C)c3c2)nc1.Cn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ccc(F)cn3)cc21.Cn1nc(OCC2CCCCC2)c2ccc(NC3=NCc4cccnc43)cc21.Cn1nc(OCC2CCCCC2)c2ncc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCOC2)c2ccc(NC(=O)c3nccnc3N)cc21.
What is the InChIKey of 3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide?
The InChIKey is JQWWLBIRZCEAJR-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H25N5O.C21H24N4O2.C20H21FN4O2.C20H24N6O2.C18H20N6O3/c1-27-19-12-17(25-21-20-16(13-24-21)8-5-11-23-20)9-10-18(19)22(26-27)28-14-15-6-3-2-4-7-15;1-14-7-10-18(22-12-14)20(26)23-16-8-9-17-19(11-16)25(2)24-21(17)27-13-15-5-3-4-6-15;1-25-18-10-15(23-19(26)17-9-6-14(21)11-22-17)7-8-16(18)20(24-25)27-12-13-4-2-3-5-13;1-26-16-10-14(24-19(27)17-15(21)8-5-9-22-17)11-23-18(16)20(25-26)28-12-13-6-3-2-4-7-13;1-24-14-8-12(22-17(25)15-16(19)21-6-5-20-15)2-3-13(14)18(23-24)27-10-11-4-7-26-9-11/h5,8-12,15H,2-4,6-7,13-14H2,1H3,(H,24,25);7-12,15H,3-6,13H2,1-2H3,(H,23,26);6-11,13H,2-5,12H2,1H3,(H,23,26);5,8-11,13H,2-4,6-7,12,21H2,1H3,(H,24,27);2-3,5-6,8,11H,4,7,9-10H2,1H3,(H2,19,21)(H,22,25).
What are the key properties of 3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide?
3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide has a molecular weight of 1857.19 g/mol, XLogP of 17.10, 24 rotatable bonds, 7 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 3-amino-N-[3-(cyclohexylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxolan-3-ylmethoxy)indazol-6-yl]pyrazine-2-carboxamide;3-(cyclohexylmethoxy)-1-methyl-N-(5H-pyrrolo[3,4-b]pyridin-7-yl)indazol-6-amine;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-fluoropyridine-2-carboxamide;N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]-5-methylpyridine-2-carboxamide is sourced from PubChem (CID 158997304), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).